Literature DB >> 23145977

Astrocytes and absence epilepsy.

Filiz Onat1.   

Abstract

UNLABELLED: This commentary discusses the importance of a new study entitled 'ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation' by Yamamura et al. () from Dr Okada's laboratory. The results from this study suggest that specific astrocyte modulating approaches should be developed for managing non-convulsive forms of epilepsy. In addition, the authors have advanced our understanding of astrocytic signalling and glial transmission. Their findings point to kynurenic acid as one of the key transmitters in the bi-directional communication between astrocytes and neurons. LINKED ARTICLE: This article is a commentary on the research paper by Yamamura et al., pp. 1088-1100 of this issue. To view this paper visit http://dx.doi.org/10.1111/j.1476-5381.2012.02132.x.
© 2012 The Author. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23145977      PMCID: PMC3594668          DOI: 10.1111/bph.12050

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

Review 1.  Do astrocytes really exocytose neurotransmitters?

Authors:  Nicola B Hamilton; David Attwell
Journal:  Nat Rev Neurosci       Date:  2010-04       Impact factor: 34.870

2.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

3.  Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).

Authors:  Robert S Fisher; Walter van Emde Boas; Warren Blume; Christian Elger; Pierre Genton; Phillip Lee; Jerome Engel
Journal:  Epilepsia       Date:  2005-04       Impact factor: 5.864

4.  Specific alteration in the expression of glial fibrillary acidic protein, glutamate dehydrogenase, and glutamine synthetase in rats with genetic absence epilepsy.

Authors:  M Dutuit; M Didier-Bazès; M Vergnes; M Mutin; A Conjard; H Akaoka; M F Belin; M Touret
Journal:  Glia       Date:  2000-10       Impact factor: 7.452

5.  Astrocytes may play a role in the etiology of absence epilepsy: a comparison between immature GAERS not yet expressing seizures and adults.

Authors:  Torun Margareta Melø; Ursula Sonnewald; Irén Aina Bastholm; Astrid Nehlig
Journal:  Neurobiol Dis       Date:  2007-07-17       Impact factor: 5.996

6.  Cortical glutamate metabolism is enhanced in a genetic model of absence epilepsy.

Authors:  Torun M Melø; Ursula Sonnewald; Monique Touret; Astrid Nehlig
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-15       Impact factor: 6.200

7.  ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation.

Authors:  Satoshi Yamamura; Masamitsu Hoshikawa; Kato Dai; Hiromitsu Saito; Noboru Suzuki; Osamu Niwa; Motohiro Okada
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 8.  Astrocytic function and its alteration in the epileptic brain.

Authors:  Ronald Jabs; Gerald Seifert; Christian Steinhäuser
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

9.  Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.

Authors:  A Vezzani; M Conti; A De Luigi; T Ravizza; D Moneta; F Marchesi; M G De Simoni
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

10.  Enhanced tonic GABAA inhibition in typical absence epilepsy.

Authors:  David W Cope; Giuseppe Di Giovanni; Sarah J Fyson; Gergely Orbán; Adam C Errington; Magor L Lorincz; Timothy M Gould; David A Carter; Vincenzo Crunelli
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.